Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Titel:
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Auteur:
Paul, Mical Daikos, George L Durante-Mangoni, Emanuele Yahav, Dafna Carmeli, Yehuda Benattar, Yael Dishon Skiada, Anna Andini, Roberto Eliakim-Raz, Noa Nutman, Amir Zusman, Oren Antoniadou, Anastasia Pafundi, Pia Clara Adler, Amos Dickstein, Yaakov Pavleas, Ioannis Zampino, Rosa Daitch, Vered Bitterman, Roni Zayyad, Hiba Koppel, Fidi Levi, Inbar Babich, Tanya Friberg, Lena E Mouton, Johan W Theuretzbacher, Ursula Leibovici, Leonard